Search

Your search keyword '"Garnier, E"' showing total 720 results
Start Over Author "Garnier, E"
720 results on '"Garnier, E"'

1. Flow separation control design with experimental validation

Author

Arnoult, T., Acher, G., Nowinski, V., Vuillemin, P., Briat, C., Pernod, P., Ghouila-Houri, C., Talbi, A., Garnier, E., and Poussot-Vassal, C.

Subjects
Electrical Engineering and Systems Science - Systems and Control
Abstract

Flow control aims at modifying a natural flow state to reach an other flow state considered as advantageous. In this paper, active feedback flow separation control is investigated with two different closed-loop control strategies, involving a reference signal tracking architecture. Firstly, a data-driven control law, leading to a linear (integral) controller is employed. Secondly, a phenomenological/model-driven approach, leading to a non-linear positive (integral) control strategy is investigated. While the former benefits of a tuning simplicity, the latter prevents undesirable effects and formally guarantees closed-loop stability. Both control approaches were validated through wind tunnel experiments of flow separation over a movable NACA 4412 plain flap. These control laws were designed with respect to hot film measurements, performed over the flap for different deflection angles. Both control approaches proved efficient in avoiding flow separation. The main contribution of this work is to provide practitioners simple but yet efficient ways to design a flow separation controller. In addition, a complete validation campaign data-set is provided.

Published
2023

6. Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

Author

Raymond, Stéphanie, Nicot, Florence, Pallier, Coralie, Bellecave, Pantxika, Maillard, Anne, Trabaud, Mary Anne, Morand-Joubert, Laurence, Rodallec, Audrey, Amiel, Corinne, Mourez, Thomas, Bocket, Laurence, Beby-Defaux, Agnès, Bouvier-Alias, Magali, Lambert-Niclot, Sidonie, Charpentier, Charlotte, Malve, Brice, Mirand, Audrey, Dina, Julia, Le Guillou-Guillemette, Hélène, Marque-Juillet, Stéphanie, Signori-Schmuck, Anne, Barin, Francis, Si-Mohamed, Ali, Fenoel, Véronique Avettand, Roussel, Catherine, Calvez, Vincent, Saune, Karine, Marcelin, Anne Geneviève, Rodriguez, Christophe, Descamps, Diane, Izopet, Jacques, Lagier, E, Roussel, C, Le Guillou-Guillemette, H, Alloui, C, Bettinger, D, Pallier, C, Fleury, H, Reigadas, S, Bellecave, P, Recordon-Pinson, P, Payan, C, Vallet, S, Vabret, A, Dina, J, Henquell, C, Mirand, A, Bouvier-Alias, M, de Rougemont, A, Dos Santos, G, Morand, P, Signori-Schmuck, A, Bocket, L, Rogez, S, Andre, P, Tardy, JC, Trabaud, MA, Tamalet, C, Delamare, C, Montes, B, Schvoerer, E, Ferré, V, André-Garnier, E, Cottalorda, J, Guinard, J, Guiguon, A, Descamps, D, Brun-Vézinet, F, Charpentier, C, Visseaux, B, Peytavin, G, Krivine, A, Si-Mohamed, A, Avettand-Fenoel, V, Marcelin, AG, Calvez, V, Lambert-Niclot, S, Soulié, C, Wirden, M, Morand-Joubert, L, Delaugerre, C, Chaix, ML, Amiel, C, Schneider, V, Giraudeau, G, Defaux, A Beby-, Brodard, V, Maillard, A, Plantier, JC, Chaplain, C, Bourlet, T, Fafi-Kremer, S, Stoll-Keller, F, Schmitt, MP, Barth, H, Yerly, S, Poggi, C, Izopet, J, Raymond, S, and Barin, F

Subjects
Medical Microbiology, Biomedical and Clinical Sciences, Clinical Sciences, Immunology, Antimicrobial Resistance, Genetics, HIV/AIDS, Clinical Research, Infectious Diseases, Aetiology, 2.1 Biological and endogenous factors, Infection, Good Health and Well Being, Adult, Drug Resistance, Viral, Female, Genetic Variation, HIV Infections, HIV-1, Humans, Male, Mutation, Rilpivirine, Viral Load, minority resistant variants, rilpivirine, first-line antiretroviral therapy, ultra-deep sequencing, French National Agency for Research on AIDS and Viral Hepatitis (ANRS) AC11 Resistance Study Group, Biological Sciences, Medical and Health Sciences, Microbiology, Clinical sciences
Abstract

BackgroundMinority resistant variants of human immunodeficiency virus type 1 (HIV-1) could influence the virological response to treatment based on nonnucleoside reverse transcriptase inhibitors (NNRTIs). Data on minority rilpivirine-resistant variants are scarce. This study used next-generation sequencing (NGS) to identify patients harboring minority resistant variants to nucleos(t)ide reverse transcriptase inhibitors and NNRTIs and to assess their influence on the virological response (VR).MethodsAll the subjects, 541 HIV-1-infected patients started a first-line regimen containing rilpivirine. VR was defined as a HIV-1 RNA load 20% in 29% of samples. We identified 43 (8.8%) and 36 (7.4%) patients who harbored rilpivirine-resistant variants with a 1% sensitivity threshold according to the French National Agency for Research on AIDS and Viral Hepatitis and Stanford algorithms, respectively. The VR was 96.9% at month 12. Detection of minority rilpivirine resistant variants was not associated with virological failure (VF). Multivariate analysis indicated that VF at month 12 was associated with a CD4 count

Published
2018

8. Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

Author

Fourati, Slim, Charpentier, Charlotte, Amiel, Corinne, Morand-Joubert, Laurence, Reigadas, Sandrine, Trabaud, Mary-Anne, Delaugerre, Constance, Nicot, Florence, Rodallec, Audrey, Maillard, Anne, Mirand, Audrey, Jeulin, Hélène, Montès, Brigitte, Barin, Francis, Bettinger, Dominique, Le Guillou-Guillemette, Hélène, Vallet, Sophie, Signori-Schmuck, Anne, Descamps, Diane, Calvez, Vincent, Flandre, Philippe, Marcelin, Anne-Genevieve, Lagier, E, Roussel, C, Le Guillou, H, Alloui, C, Bettinger, D, Pallier, C, Fleury, H, Reigadas, S, Bellecave, P, Recordon-Pinson, P, Payan, C, Vallet, S, Vabret, A, Henquell, C, Mirand, A, Bouvier-Alias, M, de Rougemont, A, Dos Santos, G, Morand, P, Signori-Schmuck, A, Bocket, L, Rogez, S, Andre, P, Tardy, JC, Trabaud, MA, Tamalet, C, Delamare, C, Montes, B, Schvoerer, E, Ferre, V, André-Garnier, E, Cottalorda, J, Guinard, J, Guiguon, A, Descamps, D, Brun-Vézinet, F, Charpentier, C, Visseaux, B, Peytavin, G, Krivine, A, Si-Mohamed, A, Avettand-Fenoel, V, Marcelin, AG, Calvez, V, Lambert-Niclot, S, Soulié, C, Wirden, M, Morand-Joubert, L, Delaugerre, C, Chaix, ML, Amiel, C, Schneider, V, Giraudeau, G, Brodard, V, Maillard, A, Plantier, JC, Chaplain, C, Bourlet, T, Fafi-Kremer, S, Stoll-Keller, F, Schmitt, MP, Barth, H, Yerly, S, Poggi, C, Izopet, J, Raymond, S, Barin, F, Chaillon, A, Marque-Juillet, S, Roque-Afonso, AM, Haïm-Boukobza, S, Flandre, P, Grudé, M, Assoumou, L, Costagliola, D, Allegre, T, Schmit, JL, and Chennebault, JM

Subjects
Medical Microbiology, Biomedical and Clinical Sciences, Infectious Diseases, Genetics, Aetiology, 2.1 Biological and endogenous factors, Infection, Adult, Anti-HIV Agents, Drug Resistance, Viral, Female, France, HIV Infections, HIV Integrase, HIV Protease, HIV Reverse Transcriptase, HIV-1, Heterocyclic Compounds, 3-Ring, Humans, Male, Middle Aged, Mutant Proteins, Oxazines, Piperazines, Pyridones, Quinolones, Raltegravir Potassium, Sequence Analysis, DNA, integrase, inhibitors, mutations, patterns, ANRS AC11 Resistance Study Group, Microbiology, Pharmacology and Pharmaceutical Sciences, Clinical sciences, Pharmacology and pharmaceutical sciences
Abstract

ObjectivesThe objectives of this study were to determine the prevalence and patterns of resistance to integrase strand transfer inhibitors (INSTIs) in patients experiencing virological failure on raltegravir-based ART and the impact on susceptibility to INSTIs (raltegravir, elvitegravir and dolutegravir).Patients and methodsData were collected from 502 treatment-experienced patients failing a raltegravir-containing regimen in a multicentre study. Reverse transcriptase, protease and integrase were sequenced at failure for each patient. INSTI resistance-associated mutations investigated were those included in the last ANRS genotypic algorithm (v23).ResultsAmong the 502 patients, at failure, median baseline HIV-1 RNA (viral load) was 2.9 log10 copies/mL. Patients had been previously exposed to a median of five NRTIs, one NNRTI and three PIs. Seventy-one percent harboured HIV-1 subtype B and the most frequent non-B subtype was CRF02_AG (13.3%). The most frequent mutations observed were N155H/S (19.1%), Q148G/H/K/R (15.4%) and Y143C/G/H/R/S (6.7%). At failure, viruses were considered as fully susceptible to all INSTIs in 61.0% of cases, whilst 38.6% were considered as resistant to raltegravir, 34.9% to elvitegravir and 13.9% to dolutegravir. In the case of resistance to raltegravir, viruses were considered as susceptible to elvitegravir in 11% and to dolutegravir in 64% of cases. High HIV-1 viral load at failure (P

Published
2015

9. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

Author

Soulie, C, Descamps, D, Grude, M, Schneider, V, Trabaud, M-A, Morand-Joubert, L, Delaugerre, C, Montes, B, Barin, F, Ferre, V, Raymond, S, Jeulin, H, Alloui, C, Yerly, S, Pallier, C, Reigadas, S, Signori-Schmuck, A, Guigon, A, Fafi-Kremer, S, Haim-Boukobza, S, Mirand, A, Maillard, A, Vallet, S, Roussel, C, Assoumou, L, Calvez, V, Flandre, P, Marcelin, A-G, Lagier, E, Le Guillou, H, Bettinger, D, Fleury, H, Bellecave, P, Recordon-Pinson, P, Payan, C, Vabret, A, Henquell, C, Bouvier-Alias, M, de Rougemont, A, Dos Santos, G, Morand, P, Bocket, L, Rogez, S, Andre, P, Tardy, JC, Trabaud, MA, Tamalet, C, Delamare, C, Schvoerer, E, Andre-Garnier, E, Cottalorda, J, Guinard, J, Guiguon, A, Brun-Vezinet, F, Charpentier, C, Visseaux, B, Peytavin, G, Krivine, A, Si-Mohamed, A, Avettand-Fenoel, V, Marcelin, AG, Lambert-Niclot, S, Wirden, M, Chaix, ML, Amiel, C, Giraudeau, G, Brodard, V, Plantier, JC, Chaplain, C, Bourlet, T, Stoll-Keller, F, Schmitt, MP, Barth, H, Poggi, C, Izopet, J, Chaillon, A, Marque-Juillet, S, and Roque-Afonso, AM

Subjects
Medical Microbiology, Biomedical and Clinical Sciences, Clinical Sciences, HIV/AIDS, Infectious Diseases, Antimicrobial Resistance, Genetics, Clinical Research, Neurosciences, Infection, Adult, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Drug Resistance, Viral, Female, Genotype, HIV Infections, HIV-1, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Mutation, Nervous System Diseases, Viral Load, ANRS Resistance AC11 Group, ARV, CSF, HIV, resistance, Microbiology, Pharmacology and Pharmaceutical Sciences, Clinical sciences, Pharmacology and pharmaceutical sciences
Abstract

OBJECTIVES: The neurological disorders in HIV-1-infected patients remain prevalent. The HIV-1 resistance in plasma and CSF was compared in patients with neurological disorders in a multicentre study. METHODS: Blood and CSF samples were collected at time of neurological disorders for 244 patients. The viral loads were >50 copies/mL in both compartments and bulk genotypic tests were realized. RESULTS: On 244 patients, 89 and 155 were antiretroviral (ARV) naive and ARV treated, respectively. In ARV-naive patients, detection of mutations in CSF and not in plasma were reported for the reverse transcriptase (RT) gene in 2/89 patients (2.2%) and for the protease gene in 1/89 patients (1.1%). In ARV-treated patients, 19/152 (12.5%) patients had HIV-1 mutations only in the CSF for the RT gene and 30/151 (19.8%) for the protease gene. Two mutations appeared statistically more prevalent in the CSF than in plasma: M41L (P=0.0455) and T215Y (P=0.0455). CONCLUSIONS: In most cases, resistance mutations were present and similar in both studied compartments. However, in 3.4% of ARV-naive and 8.8% of ARV-treated patients, the virus was more resistant in CSF than in plasma. These results support the need for genotypic resistance testing when lumbar puncture is performed.

Published
2015

30. Compressible Turbulence Dynamics

Author

Garnier, E., Adams, N., Sagaut, P., Chattot, J.-J., editor, Colella, P., editor, Eist, W., editor, Glowinski, R., editor, Hussaini, Y., editor, Joly, P., editor, Keller, H. B., editor, Marsden, J. E., editor, Meiron, D. I., editor, Pironneau, O., editor, Quarteroni, A., editor, Rappaz, J., editor, Rosner, R., editor, Sagaut, P., editor, Seinfeld, J. H., editor, Szepessy, A., editor, Wheeler, M. F., editor, Garnier, E., and Adams, N.

Published
2009
Full Text
View/download PDF

31. Relation Between SGS Model and Numerical Discretization

Author

Garnier, E., Adams, N., Sagaut, P., Chattot, J.-J., editor, Colella, P., editor, Eist, W., editor, Glowinski, R., editor, Hussaini, Y., editor, Joly, P., editor, Keller, H. B., editor, Marsden, J. E., editor, Meiron, D. I., editor, Pironneau, O., editor, Quarteroni, A., editor, Rappaz, J., editor, Rosner, R., editor, Sagaut, P., editor, Seinfeld, J. H., editor, Szepessy, A., editor, Wheeler, M. F., editor, Garnier, E., and Adams, N.

Published
2009
Full Text
View/download PDF

32. Boundary Conditions for Large-Eddy Simulation of Compressible Flows

Author

Garnier, E., Adams, N., Sagaut, P., Chattot, J.-J., editor, Colella, P., editor, Eist, W., editor, Glowinski, R., editor, Hussaini, Y., editor, Joly, P., editor, Keller, H. B., editor, Marsden, J. E., editor, Meiron, D. I., editor, Pironneau, O., editor, Quarteroni, A., editor, Rappaz, J., editor, Rosner, R., editor, Sagaut, P., editor, Seinfeld, J. H., editor, Szepessy, A., editor, Wheeler, M. F., editor, Garnier, E., and Adams, N.

Published
2009
Full Text
View/download PDF

33. Subsonic Applications with Compressibility Effects

Author

Garnier, E., Adams, N., Sagaut, P., Chattot, J.-J., editor, Colella, P., editor, Eist, W., editor, Glowinski, R., editor, Hussaini, Y., editor, Joly, P., editor, Keller, H. B., editor, Marsden, J. E., editor, Meiron, D. I., editor, Pironneau, O., editor, Quarteroni, A., editor, Rappaz, J., editor, Rosner, R., editor, Sagaut, P., editor, Seinfeld, J. H., editor, Szepessy, A., editor, Wheeler, M. F., editor, Garnier, E., and Adams, N.

Published
2009
Full Text
View/download PDF

34. Supersonic Applications

Author

Garnier, E., Adams, N., Sagaut, P., Chattot, J.-J., editor, Colella, P., editor, Eist, W., editor, Glowinski, R., editor, Hussaini, Y., editor, Joly, P., editor, Keller, H. B., editor, Marsden, J. E., editor, Meiron, D. I., editor, Pironneau, O., editor, Quarteroni, A., editor, Rappaz, J., editor, Rosner, R., editor, Sagaut, P., editor, Seinfeld, J. H., editor, Szepessy, A., editor, Wheeler, M. F., editor, Garnier, E., and Adams, N.

Published
2009
Full Text
View/download PDF

35. Explicit Structural Modeling

Author

Garnier, E., Adams, N., Sagaut, P., Chattot, J.-J., editor, Colella, P., editor, Eist, W., editor, Glowinski, R., editor, Hussaini, Y., editor, Joly, P., editor, Keller, H. B., editor, Marsden, J. E., editor, Meiron, D. I., editor, Pironneau, O., editor, Quarteroni, A., editor, Rappaz, J., editor, Rosner, R., editor, Sagaut, P., editor, Seinfeld, J. H., editor, Szepessy, A., editor, Wheeler, M. F., editor, Garnier, E., and Adams, N.

Published
2009
Full Text
View/download PDF

36. LES Governing Equations

Author

Garnier, E., Adams, N., Sagaut, P., Chattot, J.-J., editor, Colella, P., editor, Eist, W., editor, Glowinski, R., editor, Hussaini, Y., editor, Joly, P., editor, Keller, H. B., editor, Marsden, J. E., editor, Meiron, D. I., editor, Pironneau, O., editor, Quarteroni, A., editor, Rappaz, J., editor, Rosner, R., editor, Sagaut, P., editor, Seinfeld, J. H., editor, Szepessy, A., editor, Wheeler, M. F., editor, Garnier, E., and Adams, N.

Published
2009
Full Text
View/download PDF

37. Introduction

Author

Garnier, E., Adams, N., Sagaut, P., Chattot, J.-J., editor, Colella, P., editor, Eist, W., editor, Glowinski, R., editor, Hussaini, Y., editor, Joly, P., editor, Keller, H. B., editor, Marsden, J. E., editor, Meiron, D. I., editor, Pironneau, O., editor, Quarteroni, A., editor, Rappaz, J., editor, Rosner, R., editor, Sagaut, P., editor, Seinfeld, J. H., editor, Szepessy, A., editor, Wheeler, M. F., editor, Garnier, E., and Adams, N.

Published
2009
Full Text
View/download PDF

38. Functional Modeling

Author

Garnier, E., Adams, N., Sagaut, P., Chattot, J.-J., editor, Colella, P., editor, Eist, W., editor, Glowinski, R., editor, Hussaini, Y., editor, Joly, P., editor, Keller, H. B., editor, Marsden, J. E., editor, Meiron, D. I., editor, Pironneau, O., editor, Quarteroni, A., editor, Rappaz, J., editor, Rosner, R., editor, Sagaut, P., editor, Seinfeld, J. H., editor, Szepessy, A., editor, Wheeler, M. F., editor, Garnier, E., and Adams, N.

Published
2009
Full Text
View/download PDF

39. Supersonic Applications with Shock-Turbulence Interaction

Author

Garnier, E., Adams, N., Sagaut, P., Chattot, J.-J., editor, Colella, P., editor, Eist, W., editor, Glowinski, R., editor, Hussaini, Y., editor, Joly, P., editor, Keller, H. B., editor, Marsden, J. E., editor, Meiron, D. I., editor, Pironneau, O., editor, Quarteroni, A., editor, Rappaz, J., editor, Rosner, R., editor, Sagaut, P., editor, Seinfeld, J. H., editor, Szepessy, A., editor, Wheeler, M. F., editor, Garnier, E., and Adams, N.

Published
2009
Full Text
View/download PDF

42. Experimental and Numerical Study of Unsteadiness in Boundary Layer / Shock Wave Interaction

Author

Larchevêque, L., Dupont, P., de Martel, E., Garnier, E., Debiève, J. -F., Hirschel, Ernst Heinrich, editor, Schröder, Wolfgang, editor, Fujii, Kozo, editor, Haase, Werner, editor, van Leer, Bram, editor, Leschziner, Michael A., editor, Pandolfi, Maurizio, editor, Periaux, Jacques, editor, Rizzi, Arthur, editor, Roux, Bernard, editor, Shokin, Yurii I., editor, Deville, Michel, editor, Lê, Thien-Hiep, editor, and Sagaut, Pierre, editor

Published
2010
Full Text
View/download PDF

44. No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France

Author

Cuzin, L, Yazdanpanah, Y, Huleux, T, Cotte, L, Pugliese, P, Allavena, C, Reynes, J, Poizot‐Martin, I, Bani‐Sadr, F, Delpierre, C, Brégigeon, S, Zaegel‐Faucher, O, Obry‐Roguet, V, Orticoni, M, Soavi, MJ, Luquet‐Besson, I, Ressiot, E, Carta‐Padovani, M, Ducassou, MJ, Bertone, H, Galie, S, Galinier, A, Monclar, M, Martinet, P, Ritleng, AS, Ivanova, A, Blanco‐Betancourt, C, Lions, C, Alvarez, M, Biezunski, N, Debard, A, Delobel, P, Fourcade, C, Marchou, B, Martin‐Blondel, G, Porte, L, Mularczyk, M, Garipuy, D, Saune, K, Lepain, I, Marcel, M, Puntis, E, Ceppi, C, Cua, E, Cottalorda, J, Dellamonica, P, Demonchy, E, Dunais, B, Durant, J, Etienne, C, Ferrando, S, Fuzibet, JG, Garraffo, R, Risso, K, Mondain, V, Naqvi, A, Oran, N, Perbost, I, Pillet, S, Prouvost‐Keller, B, Pradier, C, Wehrlen‐Pugliese, S, Rosenthal, E, Sausse, S, Roger, PM, Bernaud, C, Billaud, E, Biron, C, Bonnet, B, Bouchez, S, Boutoille, D, Brunet‐Cartier, C, Hall, N, Jovelin, T, Morineau, P, Raffi, F, Reliquet, V, Hue, H, Larmet, L, Pineau, So, Ferré, V, André‐Garnier, E, Rodallec, A, Vivrel, F, Lefebvre, M, Grossi, O, Biron, C, Point, P, Aubry, O, Cheret, A, Choisy, P, Landman, R, Duvivier, C, Valantin, MA, Agher, R, Katlama, C, Lortholary, Avettand‐Fenoel, V, Rouzioux, C, Consigny, PH, Cessot, G, Touam, F, Usubillaga, R, Benhadj, K, Cabié, A, Abel, S, Pierre‐François, S, Ouka, M, Martial, J, Rey, D, Ebel, E, Fischer, P, Partisani, M, Cheneau, C, Priester, M, Batard, ML, Bernard‐Henry, C, e Mautort, E, Chirouze, C, Drobacheff‐Thiébaut, C, Faller, JP, Faucher, JF, Foltzer, A, Gil, H, Hustache‐Mathieu, L, Hoen, B, Jacomet, C, Laurichesse, H, Lesens, O, Vidal, M, Mrozek, N, Aumeran, C, Baud, O, Beytout, J, Coban, D, Casanova, S, Rouger, C, Berger, JL, NʼGuyen, Y, Lambert, D, Kmiec, I, Hentzien, M, Peyramond, D, Chidiac, C, Ader, F, Biron, F, Boibieux, A, Ferry, T, Miailhes, P, Perpoint, T, Degroodt, S, Atoui, N, Casanova, ML, Le Moing, V, Makinson, A, Meftah, N, Merle De Boever, C, Montes, B, and Psomas, C

Published
2018
Full Text
View/download PDF

45. ONERA/IEMN Contribution within the ADVACT Program: Actuators Evaluation

Author

Garnier, E., Pruvost, M., Ducloux, O., Talbi, A., Gimeno, L., Pernod, P., Merlen, A., Preobrazhensky, V., Gladwell, G. L. M., editor, Moreau, R., editor, Engelbrecht, J., editor, Freund, L. B., editor, Kluwick, A., editor, Moffatt, H. K., editor, Olhoff, N., editor, Tsutomu, K., editor, van Campen, D., editor, Zheng, Z., editor, Morrison, J. F., editor, Birch, D. M., editor, and Lavoie, P., editor

Published
2008
Full Text
View/download PDF

48. No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy

Author

Lajaunie, Rébecca, Cuzin, Lise, Palich, Romain, Makinson, Alain, Bani-Sadr, Firouzé, Duvivier, Claudine, Arvieux, Cedric, Rey, David, Poizot-Martin, Isabelle, Delpierre, Cyril, Delobel, Pierre, Martin-Blondel, Guillaume, Chirouze, C., Drobacheff-Thiébaut, C., Foltzer, A., Bouiller, K., Hustache- Mathieu, L., Lepiller, Q., Bozon, F., Babre, O, Brunel, As., Muret, P., Chevalier, E., Jacomet, C., Laurichesse, H., Lesens, O., Vidal, M., Mrozek, N., Aumeran, C., Baud, O., Corbin, V., Goncalvez, E., Mirand, A, Brebion, A, Henquell, C, Lamaury, I., Fabre, I., Curlier, E., Ouissa, R., Herrmann-Storck, C., Tressieres, B., Receveur, Mc., Boulard, F., Daniel, C., Clavel, C., Roger, Pm., Markowicz, S., Chellum Rungen, N., Merrien, D., Perré, P., Guimard, T., Bollangier, O., Leautez, S., Morrier, M., Laine, L., Boucher, D., Point, P., Cotte, L., Ader, F., Becker, A., Boibieux, A., Brochier, C., Brunel-Dalmas, F., Cannesson, O., Chiarello, P., Chidiac, C., Degroodt, S., Ferry, T., Godinot, M., Livrozet, J.M., Makhloufi, D., Miailhes, P., Perpoint, T., Perry, M., Pouderoux, C., Roux, S., Triffault-Fillit, C., Valour, F., Charre, C., Icard, V., Tardy, J.C., Trabaud, M.A., Ravaux, I., Ménard, A., Belkhir, Ay., Colson, P., Dhiver, C., Madrid, A., Martin-Degioanni, M., Meddeb, L., Mokhtari, M., Motte, A., Raoux, A., Toméi, C., Tissot-Dupont, H., Poizot-Martin, I., Brégigeon, S., Zaegel-Faucher, O., Obry-Roguet, V., Laroche, H, Orticoni, M., Soavi, M.J., Ressiot, E., Ducassou, M.J., Jaquet, I., Galie, S., Colson, H., Ritleng, A.S., Ivanova, A., Debreux, C., Lions, C., Rojas-Rojas, T, Cabié, A., Abel, S., Bavay, J., Bigeard, B., Cabras, O., Cuzin, L., Dupin de Majoubert, R., Fagour, L., Guitteaud, K., Marquise, A., Najioullah, F., Pierre-François, S., Pasquier, J., Richard, P., Rome, K., Turmel, Jm, Varache, C., Atoui, N., Bistoquet, M., Delaporte, E, Le Moing, V., Makinson, A., Meftah, N., Merle de Boever, C., Montes, B., Montoya Ferrer, A., Tuaillon, E., Reynes, J., Lefèvre, B., Jeanmaire, E., Hénard, S., Frentiu, E., Charmillon, A., Legoff, A., Tissot, N., André, M., Boyer, L., Bouillon, Mp., Delestan, M., Goehringer, F., Bevilacqua, S., Rabaud, C., May, T., Raffi, F., Allavena, C., Aubry, O., Billaud, E., Biron, C., Bonnet, B., Bouchez, S., Boutoille, D., Brunet-Cartier, C., Deschanvres, C., Gaborit, B.J., Grégoire, A., Grégoire, M., Grossi, O., Guéry, R., Jovelin, T., Lefebvre, M., Le Turnier, P., Lecomte, R., Morineau, P., Reliquet, V., Sécher, S., Cavellec, M., Paredes, E., Soria, A., Ferré, V., André-Garnier, E., Rodallec, A., Pugliese, P., Breaud, S., Ceppi, C., Chirio, D., Cua, E., Dellamonica, P., Demonchy, E., de Monte, A., Durant, J., Etienne, C., Ferrando, S., Garraffo, R., Michelangeli, C., Mondain, V., Naqvi, A., Oran, N., Perbost, I., Carles, M., Klotz, C., Maka, A., Pradier, C., Prouvost-Keller, B., Risso, K., Rio, V., Rosenthal, E., Touitou, I., Wehrlen-Pugliese, S., Zouzou, G., Hocqueloux, L., Prazuck, T., Gubavu, C., Sève, A., Giaché, S., Rzepecki, V., Colin, M., Boulard, C., Thomas, G., Cheret, A., Goujard, C., Quertainmont, Y., Teicher, E., Lerolle, N., Jaureguiberry, S., Colarino, R., Deradji, O., Castro, A., Barrail-Tran, A., Yazdanpanah, Y., Landman, R., Joly, V., Ghosn, J., Rioux, C., Lariven, S., Gervais, A., Lescure, Fx., Matheron, S., Louni, F., Julia, Z., Le Gac, S., Charpentier, C., Descamps, D., Peytavin, G., Duvivier, C., Aguilar, C., Alby-Laurent, F., Amazzough, K., Benabdelmoumen, G., Bossi, P., Cessot, G., Charlier, C., Consigny, P.H., Jidar, K., Lafont, E., Lanternier, F., Leporrier, J., Lortholary, O., Louisin, C., Lourenco, J., Parize, P., Pilmis, B., Rouzaud, C., Touam, F., Valantin, Ma., Tubiana, R., Agher, R., Seang, Sophie, Schneider, L., Palich, R., Blanc, C., Katlama, C., Bani-Sadr, F., Berger, Jl., N’guyen, Y., Lambert, D., Kmiec, I., Hentzien, M., Brunet, A., Romaru, J., Marty, H., Brodard, V., Arvieux, C., Tattevin, P., Revest, M., Souala, F., Baldeyrou, M., Patrat-Delon, S., Chapplain, J.M., Benezit, F., Dupont, M., Poinot, M., Maillard, A., Pronier, C., Lemaitre, F., Morlat, C., Poisson-Vannier, M., Sinteff, Jp., Gagneux-Brunon, A., Botelho-Nevers, E., Frésard, A., Ronat, V., Lucht, F., Rey, D., Fischer, P., Partisani, M., Cheneau, C., Priester, M., Batard, Ml., Mélounou, C, Bernard-Henry, C., de Mautort, E., Fafi-Kremer, S., Delobel, P., Alvarez, M., Biezunski, N., Debard, A., Delpierre, C., Gaube, G., Lansalot, P., Lelièvre, L., Marcel, M., Martin-Blondel, G., Piffaut, M., Porte, L., Saune, K., Robineau, O., Ajana, F., Aïssi, E., Alcaraz, I., Alidjinou, E., Baclet, V., Bocket, L., Boucher, A., Digumber, M., Huleux, T., Lafon-Desmurs, B., Meybeck, A., Pradier, M., Tetart, M., Thill, P., Viget, N., Valette, M., Service Maladies infectieuses et tropicales [CHU Toulouse], Pôle Inflammation, infection, immunologie et loco-moteur [CHU Toulouse] (Pôle I3LM Toulouse), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), CHU de la Martinique [Fort de France], Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Département Maladies Infectieuses et Tropicales, Hôpital Universitaire, Montpellier, France, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Centre Hospitalier Universitaire de Reims (CHU Reims), Service des Maladies infectieuses et tropicales [CHU Necker], CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Institut Cochin (IC UM3 (UMR 8104 / U1016)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Centre Médical de l'Institut Pasteur (CMIP), Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité), CHU Pontchaillou [Rennes], CHU Strasbourg, Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Toulouse III Paul Sabatier - Faculté de médecine Purpan (UTPS), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), And The Dat’AIDS study group: C Chirouze, C Drobacheff-Thiébaut, A Foltzer, K Bouiller, L Hustache-Mathieu, Q Lepiller, F Bozon, O Babre, A S Brunel, P Muret, E Chevalier, C Jacomet, H Laurichesse, O Lesens, M Vidal, N Mrozek, C Aumeran, O Baud, V Corbin, E Goncalvez, A Mirand, A Brebion, C Henquell, I Lamaury, I Fabre, E Curlier, R Ouissa, C Herrmann-Storck, B Tressieres, M C Receveur, F Boulard, C Daniel, C Clavel, P M Roger, S Markowicz, N Chellum Rungen, D Merrien, P Perré, T Guimard, O Bollangier, S Leautez, M Morrier, L Laine, D Boucher, P Point, L Cotte, F Ader, A Becker, A Boibieux, C Brochier, F Brunel-Dalmas, O Cannesson, P Chiarello, C Chidiac, S Degroodt, T Ferry, M Godinot, J M Livrozet, D Makhloufi, P Miailhes, T Perpoint, M Perry, C Pouderoux, S Roux, C Triffault-Fillit, F Valour, C Charre, V Icard, J C Tardy, M A Trabaud, I Ravaux, A Ménard, A Y Belkhir, P Colson, C Dhiver, A Madrid, M Martin-Degioanni, L Meddeb, M Mokhtari, A Motte, A Raoux, C Toméi, H Tissot-Dupont, I Poizot-Martin, S Brégigeon, O Zaegel-Faucher, V Obry-Roguet, H Laroche, M Orticoni, M J Soavi, E Ressiot, M J Ducassou, I Jaquet, S Galie, H Colson, A S Ritleng, A Ivanova, C Debreux, C Lions, T Rojas-Rojas, A Cabié, S Abel, J Bavay, B Bigeard, O Cabras, L Cuzin, R Dupin de Majoubert, L Fagour, K Guitteaud, A Marquise, F Najioullah, S Pierre-François, J Pasquier, P Richard, K Rome, J M Turmel, C Varache, N Atoui, M Bistoquet, E Delaporte, V Le Moing, A Makinson, N Meftah, C Merle de Boever, B Montes, A Montoya Ferrer, E Tuaillon, J Reynes, B Lefèvre, E Jeanmaire, S Hénard, E Frentiu, A Charmillon, A Legoff, N Tissot, M André, L Boyer, M P Bouillon, M Delestan, F Goehringer, S Bevilacqua, C Rabaud, T May, F Raffi, C Allavena, O Aubry, E Billaud, C Biron, B Bonnet, S Bouchez, D Boutoille, C Brunet-Cartier, C Deschanvres, B J Gaborit, A Grégoire, M Grégoire, O Grossi, R Guéry, T Jovelin, M Lefebvre, P Le Turnier, R Lecomte, P Morineau, V Reliquet, S Sécher, M Cavellec, E Paredes, A Soria, V Ferré, E André-Garnier, A Rodallec, P Pugliese, S Breaud, C Ceppi, D Chirio, E Cua, P Dellamonica, E Demonchy, A De Monte, J Durant, C Etienne, S Ferrando, R Garraffo, C Michelangeli, V Mondain, A Naqvi, N Oran, I Perbost, M Carles, C Klotz, A Maka, C Pradier, B Prouvost-Keller, K Risso, V Rio, E Rosenthal, I Touitou, S Wehrlen-Pugliese, G Zouzou, L Hocqueloux, T Prazuck, C Gubavu, A Sève, S Giaché, V Rzepecki, M Colin, C Boulard, G Thomas, A Cheret, C Goujard, Y Quertainmont, E Teicher, N Lerolle, S Jaureguiberry, R Colarino, O Deradji, A Castro, A Barrail-Tran, Y Yazdanpanah, R Landman, V Joly, J Ghosn, C Rioux, S Lariven, A Gervais, F X Lescure, S Matheron, F Louni, Z Julia, S Le Gac, C Charpentier, D Descamps, G Peytavin, C Duvivier, C Aguilar, F Alby-Laurent, K Amazzough, G Benabdelmoumen, P Bossi, G Cessot, C Charlier, P H Consigny, K Jidar, E Lafont, F Lanternier, J Leporrier, O Lortholary, C Louisin, J Lourenco, P Parize, B Pilmis, C Rouzaud, F Touam, M A Valantin, R Tubiana, R Agher, S Seang, L Schneider, R Palich, C Blanc, C Katlama, F Bani-Sadr, J L Berger, Y N'Guyen, D Lambert, I Kmiec, M Hentzien, A Brunet, J Romaru, H Marty, V Brodard, C Arvieux, P Tattevin, M Revest, F Souala, M Baldeyrou, S Patrat-Delon, J M Chapplain, F Benezit, M Dupont, M Poinot, A Maillard, C Pronier, F Lemaitre, C Morlat, M Poisson-Vannier, T Jovelin, J P Sinteff, A Gagneux-Brunon, E Botelho-Nevers, A Frésard, V Ronat, F Lucht, D Rey, P Fischer, M Partisani, C Cheneau, M Priester, M L Batard, C Mélounou, C Bernard-Henry, E de Mautort, S Fafi-Kremer, P Delobel, M Alvarez, N Biezunski, A Debard, C Delpierre, G Gaube, P Lansalot, L Lelièvre, M Marcel, G Martin-Blondel, M Piffaut, L Porte, K Saune, O Robineau, F Ajana, E Aïssi, I Alcaraz, E Alidjinou, V Baclet, L Bocket, A Boucher, M Digumber, T Huleux, B Lafon-Desmurs, A Meybeck, M Pradier, M Tetart, P Thill, N Viget, M Valette, Malbec, Odile, Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Toulouse (UT)-Université de Toulouse (UT), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service de Maladies Infectieuses et Tropicales [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Hospitalier Universitaire de Rennes (CHU Rennes), Laboratoire de Physique des Lasers (LPL), Université Paris 13 (UP13)-Centre National de la Recherche Scientifique (CNRS)-Université Sorbonne Paris Nord, Service d'Immuno-hématologie clinique [Hôpital Sainte Marguerite - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud ), Institut des sciences de la santé publique [Marseille] (ISSPAM), European Infective Endocarditis Registry (Euro-Endo), EMERGEN consortium, Stratégies thérapeutiques contre l'infection VIH et les maladies virales associées [iPLesp] (THERAVIR), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Laboratoire Microorganismes : Génome et Environnement (LMGE), and Centre National de la Recherche Scientifique (CNRS)-Université Clermont Auvergne (UCA)

Subjects
medicine.medical_specialty, MESH: CD4 Lymphocyte Count, [SDV]Life Sciences [q-bio], antiretroviral therapy, Human immunodeficiency virus (HIV), protease inhibitors, HIV Infections, medicine.disease_cause, MESH: HIV-1, Acquired immunodeficiency syndrome (AIDS), MESH: Neoplasm Recurrence, Local / complications, Internal medicine, medicine, Humans, HHV8, MESH: HIV Infections* / complications, MESH: Protease Inhibitors / adverse effects, Pharmacology (medical), Protease inhibitor (pharmacology), Sarcoma, Kaposi, Retrospective Studies, MESH: Humans, business.industry, Health Policy, Kaposi sarcoma, MESH: Retrospective Studies, Viral Load, MESH: HIV Infections* / drug therapy, medicine.disease, Antiretroviral therapy, switch, CD4 Lymphocyte Count, AIDS, [SDV] Life Sciences [q-bio], Regimen, Infectious Diseases, Increased risk, MESH: Sarcoma, Kaposi* / drug therapy, HIV-1, Sarcoma, Neoplasm Recurrence, Local, business, MESH: Viral Load, Viral load
Abstract

International audience; Objectives: Our aim was to assess if switching from a protease inhibitors (PI)-based regimen to a PI-free one is associated with an increased risk of Kaposi Sarcoma (KS) relapse among patients living with HIV (PLHIV) with history of KS and controlled HIV replication.Methods: In a retrospective analysis of the prospectively collected Dat'AIDS database we selected patients who both had a past KS history and a HIV-1 viral load below 200 copies/mL while being PI-treated. We searched for KS relapses while persistent virological success was maintained for at least 6 months, whether patients kept taking the PI, or switched to PI-free regimen.Results: Among the 216 patients with past KS event and a history of HIV-1 infection efficiently treated by a PI-based regimen, 148 patients (68.5%) later switched to a PI-sparing regimen. Their baseline characteristics were not different from non-switching patients. We described 7 cases of relapse (3.2% of the 216 patients). Five cases of relapse occurred in switching patients (3.4%). The remaining two relapses occurred in PI-treated patients (2.9%). At KS relapse, CD4 cell count was 459 cells/μL (range 225-560) for switching patients, compared with 362 and 136 cells/μL for the other two patients.Conclusions: In this large cohort of PLHIV with a history of KS and ART-controlled HIV replication, KS relapses were described in 3.2% of the patients, and were not more frequent when a PI-containing ART regimen has been switched to a PI-free regimen. Our results do not support a specific effect of PI on KS.

Published
2022

49. The global spectrum of plant form and function: enhanced species-level trait dataset

Author

Díaz, S., Kattge, J., Cornelissen, J.H.C., Wright, I.J., Lavorel, S., Dray, S., Reu, B., Kleyer, M., Wirth, C., Prentice, I.C., Garnier, E., Bönisch, G., Westoby, M., Poorter, H., Reich, P.B., Moles, A.T., Dickie, J., Zanne, A.E., Chave, J., Wright, S.J., Sheremetiev, S.N., Jactel, H., Baraloto, C., Cerabolini, B.E.L., Pierce, S., Shipley, B., Casanoves, F., Joswig, J.S., Günther, A., Falczuk, V., Mahecha, M.D., Gorné, L.D., Amiaud, B., Atkin, O.K., Bahn, M., Baldocchi, D., Beckmann, Michael, Blonder, B., Bond, W., Bond-Lamberty, B., Brown, K., Burrascano, S., Byun, C., Campetella, G., Cavender-Bares, J., Stuart Chapin III, F., Choat, B., Coomes, D.A., Cornwell, W.K., Craine, J., Craven, D., Dainese, M., de Araujo, A.C., de Vries, F.T., Ferreira Domingues, T., Enquist, B.J., Fagúndez, J., Fang, J., Fernández-Méndez, F., Fernandez-Piedade, M.T., Ford, H., Forey, E., Freschet, G.T., Gachet, S., Gallagher, R., Green, W., Guerin, G.R., Gutiérrez, A.G., Harrison, S.P., Hattingh, W.N., He, T., Hickler, T., Higgins, S.I., Higuchi, P., Ilic, J., Jackson, R.B., Jalili, A., Jansen, S., Koike, F., König, C., Kraft, N., Kramer, K., Kreft, H., Kühn, Ingolf, Kurokawa, H., Lamb, E.G., Laughlin, D.C., Leishman, M., Lewis, S., Louault, F., Malhado, A.C.M., Manning, P., Meir, P., Mencuccini, M., Messier, J., Miller, R., Minden, V., Molofsky, J., Montgomery, R., Montserrat-Martí, G., Díaz, S., Kattge, J., Cornelissen, J.H.C., Wright, I.J., Lavorel, S., Dray, S., Reu, B., Kleyer, M., Wirth, C., Prentice, I.C., Garnier, E., Bönisch, G., Westoby, M., Poorter, H., Reich, P.B., Moles, A.T., Dickie, J., Zanne, A.E., Chave, J., Wright, S.J., Sheremetiev, S.N., Jactel, H., Baraloto, C., Cerabolini, B.E.L., Pierce, S., Shipley, B., Casanoves, F., Joswig, J.S., Günther, A., Falczuk, V., Mahecha, M.D., Gorné, L.D., Amiaud, B., Atkin, O.K., Bahn, M., Baldocchi, D., Beckmann, Michael, Blonder, B., Bond, W., Bond-Lamberty, B., Brown, K., Burrascano, S., Byun, C., Campetella, G., Cavender-Bares, J., Stuart Chapin III, F., Choat, B., Coomes, D.A., Cornwell, W.K., Craine, J., Craven, D., Dainese, M., de Araujo, A.C., de Vries, F.T., Ferreira Domingues, T., Enquist, B.J., Fagúndez, J., Fang, J., Fernández-Méndez, F., Fernandez-Piedade, M.T., Ford, H., Forey, E., Freschet, G.T., Gachet, S., Gallagher, R., Green, W., Guerin, G.R., Gutiérrez, A.G., Harrison, S.P., Hattingh, W.N., He, T., Hickler, T., Higgins, S.I., Higuchi, P., Ilic, J., Jackson, R.B., Jalili, A., Jansen, S., Koike, F., König, C., Kraft, N., Kramer, K., Kreft, H., Kühn, Ingolf, Kurokawa, H., Lamb, E.G., Laughlin, D.C., Leishman, M., Lewis, S., Louault, F., Malhado, A.C.M., Manning, P., Meir, P., Mencuccini, M., Messier, J., Miller, R., Minden, V., Molofsky, J., Montgomery, R., and Montserrat-Martí, G.

Abstract

Here we provide the ‘Global Spectrum of Plant Form and Function Dataset’, containing species mean values for six vascular plant traits. Together, these traits –plant height, stem specific density, leaf area, leaf mass per area, leaf nitrogen content per dry mass, and diaspore (seed or spore) mass – define the primary axes of variation in plant form and function. The dataset is based on ca. 1 million trait records received via the TRY database (representing ca. 2,500 original publications) and additional unpublished data. It provides 92,159 species mean values for the six traits, covering 46,047 species. The data are complemented by higher-level taxonomic classification and six categorical traits (woodiness, growth form, succulence, adaptation to terrestrial or aquatic habitats, nutrition type and leaf type). Data quality management is based on a probabilistic approach combined with comprehensive validation against expert knowledge and external information. Intense data acquisition and thorough quality control produced the largest and, to our knowledge, most accurate compilation of empirically observed vascular plant species mean traits to date. Measurement(s) plant trait Technology Type(s) various Factor Type(s) none Sample Characteristic - Organism Tracheophyta Sample Characteristic - Environment natural environment Sample Characteristic - Location global

Published
2022

50. Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study

Author

Gantner, P, Cuzin, L, Allavena, C, Cabie, A, Pugliese, P, Valantin, M‐A, Bani‐Sadr, F, Joly, V, Ferry, T, Poizot‐Martin, I, Garraffo, R, Peytavin, G, Fafi‐Kremer, S, Rey, D, Billaud, E., Biron, C., Bonnet, B., Bouchez, S., Boutoille, D., Brunet, C., Jovelin, T., Hall, N., Bernaud, C., Morineau, P., Reliquet, V., Aubry, O., Point, P., Besnier, M., Grossi, O., Lefebvre, M., Hüe, H., Cavellec, M., Soria, A., Pineau, S., André‐Garnier, E., Rodallec, A., Brégigeon, S., Faucher, O., Obry‐Roguet, V., Orticoni, M., Soavi, M. J., Luquet‐Besson, I., Ressiot, E., Pinot, I., Ducassou, M. J., Bertone, H., Gallie, S., Trijau, S., Ritleng, A. S., Ivanova, A., Guignard, M., Blanco‐Betancourt, C., Alvarez, M., Biezunski, N., Debard, A., Delobel, P., Delpierre, C., Fourcade, C., Marchou, B., Martin‐Blondel, G., Porte, L., Mularczyk, M., Garipuy, D., Saune, K., Lepain, I., Marcel, M., Puntis, E., Ceppi, C., Cua, E., Cottalorda, J., Dellamonica, P., Demonchy, E., Dunais, B., Durant, J., Etienne, C., Ferrando, S., Fuzibet, J. G., Risso, K., Mondain, V., Naqvi, A., Oran, N., Perbost, I., Pillet, S., Prouvost‐Keller, B., Pradier, C., Wehrlen‐Pugliese, S., Rosenthal, E., Sausse, S., Roger, P. M., Choisy, Ph., Vandame, S., Huleux, Th., Ajana, F., Alcaraz, I., Baclet, V., Huleux, T. H., Melliez, H., Viget, N., Valette, M., Aissi, E., Allienne, Ch., Meybeck, A., Riff, B., Agher, R., Katlama, C., Duvivier, C., Yazdanpanah, Y., Landman, R., Mackoumbou‐Nkouka, C., Louni, F., Julia, Z., Charpentier, C., Descamps, D., Cotte, L., Peyramond, D., Chidiac, C., Ader, F., Biron, F., Boibieux, A., Miailhes, P., Perpoint, T., Schlienger, I., Dahoud, F., Lippmann, J., Braun, E., Koffi, J., Longuet, C., Guéripel, V., Augustin‐Normand, C., Degroodt, S., Batard, M. L., Bernard‐Henry, C., Cheneau, C., de Mautort, E., Fischer, P., Partisani, M., Priester, M., Bani‐Sadr, F., Rouger, C., Berger, J. L., NʼGuyen, Y., Lambert, D., Kmiec, I., Hentzien, M., and Lebrun, D.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results